Rejuvel Bio-Sciences, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/44338162-4cf0-4653-9a6b-92f627416d85/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-352.9k | 2014-01-01 – 2014-12-31 | evidence 0001469709-15-000204 |
| FY 2013 | $-4.2M | 2009-10-16 – 2014-03-31 | evidence 0001469709-14-000208 |
| FY 2012 | $-1.3M | 2009-10-16 – 2013-03-31 | evidence 0001469709-13-000342 |
| FY 2011 | $-462.6k | 2009-10-14 – 2012-03-31 | evidence 0001533621-12-000201 |
| FY 2010 | $-24.9k | 2010-01-01 – 2010-12-31 | evidence 0001533621-12-000077 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Rejuvel Bio-Sciences, Inc. — all facts · Revenue · Operating Income